HemaSphere (Aug 2023)
S229: PROPHYLACTIC EFFICACY OF INTRATHECAL VERSUS INTRAVENOUS METHOTREXATE FOR CNS RELAPSE IN HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA: A PHASE III RANDOMIZED, CONTROLLED STUDY
- Seung-Ah Yahng,
- Ho-Young Yhim,
- Jae-Yong Kwak,
- Ho-Jin Shin,
- Joon Ho Moon,
- Hyeon-Seok Eom,
- Ka-Won Kang,
- Yong Park,
- Min Kyoung Kim,
- Se Ryun Lee,
- Dae Sik Kim,
- Hyo Jung Kim,
- Jun Ho Yi,
- Young Rok Do,
- Hye Jin Kang,
- Sungnam Lim,
- Deok Hwan Yang
Affiliations
- Seung-Ah Yahng
- 1 Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea, Internal Medicine, Hemato-oncology division, Incheon, Korea, Rep. of South
- Ho-Young Yhim
- 2 Jeonbuk National University Medical School, Jeonju, Republic of Korea, Hematology-Oncology, Jeonju, Korea, Rep. of South
- Jae-Yong Kwak
- 2 Jeonbuk National University Medical School, Jeonju, Republic of Korea, Hematology-Oncology, Jeonju, Korea, Rep. of South
- Ho-Jin Shin
- 3 Busan National University Hospital, Busan, South Korea, Internal Medicine, Division of Hematology-Oncology, Busan, Korea, Rep. of South
- Joon Ho Moon
- 4 Kyungpook National University Hospital, Daegu, South Korea, Internal Medicine, Division of Hematology-Oncology, Daegu, Korea, Rep. of South
- Hyeon-Seok Eom
- 5 National Cancer Center, Goyang, Korea, Internal Medicine, Division of Hematology-Oncology, Goyang, Korea, Rep. of South
- Ka-Won Kang
- 6 Korea University College of Medicine, Anam Hospital, Seoul, South Korea, Internal Medicine, Division of Hematology-Oncology, Seoul, Korea, Rep. of South
- Yong Park
- 6 Korea University College of Medicine, Anam Hospital, Seoul, South Korea, Internal Medicine, Division of Hematology-Oncology, Seoul, Korea, Rep. of South
- Min Kyoung Kim
- 7 Yeungnam University College of medicine, Daegu, South Korea, Internal Medicine, Division of Hematology-Oncology, Daegu, Korea, Rep. of South
- Se Ryun Lee
- 8 Korea University College of Medicine, Ansan Hospital, Seoul, South Korea, Internal Medicine, Division of Hematology-Oncology, Seoul, Korea, Rep. of South
- Dae Sik Kim
- 9 Korea University Guro Hospital, Guro-gu, Seoul, Korea, Internal Medicine, Division of Hematology-Oncology, Seoul, Korea, Rep. of South
- Hyo Jung Kim
- 10 Hallym Medical Center, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea, Internal Medicine, Division of Hematology-Oncology, Anyang, Korea, Rep. of South
- Jun Ho Yi
- 11 Department of Medicine, Chung-Ang University, Seoul, Internal Medicine, Division of Hematology-Oncology, Seoul, Korea, Rep. of South
- Young Rok Do
- 12 Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea, Internal Medicine, Division of Hematology-Oncology, Daegu, Korea, Rep. of South
- Hye Jin Kang
- 13 Korea Institute of Radiological and Medical Sciences, Seoul, Korea, Internal Medicine, Division of Hematology-Oncology, Seoul, Korea, Rep. of South
- Sungnam Lim
- 14 Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea, Internal Medicine, Division of Hematology-Oncology, Busan, Korea, Rep. of South
- Deok Hwan Yang
- 15 Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Korea, Internal Medicine, Division of Hematology-Oncology, Gwangju, Korea, Rep. of South
- DOI
- https://doi.org/10.1097/01.HS9.0000967828.60026.bd
- Journal volume & issue
-
Vol. 7
p. e60026bd
Abstract
No abstracts available.